Dr. Pradip K. Jamnadas, MD

Dr. Jamnadas practices at Cardiovascular Interventions PA in Orlando, Florida.

Dr. Jamnadas' NPI, 1710987946, was assigned on July 29, 2005. Dr. Jamnadas graduated from University of London Faculty of Medicine in 1981. Dr. Jamnadas holds Florida license ME 54920.

Dr. Jamnadas' primary practice is Cardiovascular Interventions PA, at 1900 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 894-4880.

Dr. Jamnadas' primary practice is Cardiovascular Interventions PA in Orlando, Florida. Dr. Jamnadas is also affiliated with AdventHealth Orlando. The medical group on file is Cardiovascular Interventions. Dmand AI also links Dr. Jamnadas to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamnadas practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Jamnadas' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Jamnadas is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Jamnadas' licenses on file in 2 states: Florida and Maryland.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Jamnadas treats.

CMS data shows 31,747 Medicare services from Dr. Jamnadas across 115 procedure codes in 2024, for 1,457 Medicare patients. Medicare paid $2,542,746 for them.

CMS counts 1,457 Medicare patients who saw Dr. Jamnadas in 2024. The largest group is 65 to 74, with 712 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jamnadas' median patient age at 64, with 43% women.

In 2024, Dr. Jamnadas wrote 2,472 Medicare Part D claims for 473 patients. 73% of them were for generic drugs. CMS names the drug for 2,162 of them, across 42 drugs with 11 or more claims each, at $650,734 in total drug cost. In 2023, CMS named 1,017 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Jamnadas for performance year 2024, reported individually. Dr. Jamnadas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jamnadas as offering telehealth. CMS counts 78 procedures of coronary angioplasty and stenting by Dr. Jamnadas, more than 93% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Jamnadas. The most frequent topics are Angioplasty, Balloon, Arterial Occlusive Diseases and Intermittent Claudication. Dr. Jamnadas has published most often in Cathet Cardiovasc Diagn. Dr. Jamnadas' most frequent co-author is Hetain N. Patel, DO.

CMS Open Payments shows 546 general payments to Dr. Jamnadas from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Pfizer Inc. paid the most, $875.

Dmand AI lists 2 awards for Dr. Jamnadas, most recently CMS Stage 1 EHR in 2013.

Dr. Jamnadas graduated from University of London Faculty of Medicine in 1981.

Dr. Jamnadas is in network with 7 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.